| 87.80 Data as of May 22 |  -0.13 / -0.15%Today’s Change | 61.71 Today|||52-Week Range 89.99 | +25.25% Year-to-Date |
| Gilead's Sofosbuvir under European Review - Analyst Blog May 22 / Zacks.com | Allocate Assets to Buy-Rated Dow Stocks May 22 / TheStreet.com |
| Structuring a Trade in J&J May 22 / TheStreet.com | JNJ's Simponi Label Expanded - Analyst Blog May 21 / Zacks.com |
| Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow May 22 / TheStreet.com | Diary of a Dividend Diva: The Season Kicks Into High Gear May 20 / TheStreet.com |
| 5 Stocks Going Ex-Dividend Tomorrow: SMG, FMER, AIZ, KEY, JNJ May 22 / TheStreet.com | Stock Market News for May 14, 2013 - Market News May 14 / Zacks.com |
| Stock Market News for May 22, 2013 - Market News May 22 / Zacks.com | Stock Market News for May 13, 2013 - Market News May 13 / Zacks.com |
| Previous close | 88.59 |
| Today’s open | 88.70 |
| Day’s range | -- - -- |
| Volume | 13,798,024 |
| Average volume (3 months) | 9,782,655 |
| Market cap | $248.8B |
| Dividend yield | 3.01% |
| Earnings growth (last year) | +10.60% |
| Earnings growth (this year) | +6.11% |
| Earnings growth (next 5 years) | +6.40% |
| Revenue growth (last year) | +3.45% |
| P/E ratio | 23.9 |
| Price/Sales | 2.84 |
| Price/Book | 3.80 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer Inc | +0.52 | +1.81% |
| NVSNovartis AG | -0.01 | -0.01% |
| SNYSanofi SA | 0.00 | 0.00% |
| MRKMerck & Co Inc | -0.62 | -1.31% |
| Next reporting date | July 16, 2013 |
| EPS forecast (this quarter) | $1.39 |
| Annual revenue (last year) | $67.3B |
| Annual profit (last year) | $10.9B |
| Net profit margin | 16.13% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Alex Gorsky, MBA |
Chief Financial Officer & Vice President Dominic J. Caruso |
Corporate headquarters New Brunswick, New Jersey |
.
